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http://dx.doi.org/10.1016/j.kjms.201Abstract Super scan pattern on technetium-99m methyldiphosphonate (Tc-99m MDP) bone
scintigraphy is a special condition of extremely high bone uptake relative to soft tissue with
absent or faint renal radioactivity visualization, which is usually seen in diffuse bone metas-
tases or discrete endocrine entities. Here, two cases with super bone scan are presented.
One was a young man diagnosed with gastric cancer. The other was a middle-aged woman with
a history of breast cancer with recent recurrence. Both cases had 18-fluorodeoxyglucose posi-
tron emission tomography/computed tomography (18F-FDG PET/CT) diagnosis simultaneously.
Based on imaging of 18F-FDG PET/CT, diffusely incremental 18F-FDG avidity in spine/pelvis on
PET and subtle erosion of cortical bone on CT were seen. The cytological results of bone
marrow biopsy showed evidence of malignant metastasis. However, there were several focal
discrepant findings between the 18F-FDG PET/CT and Tc-99m MDP bone scan. According to inte-
gration of both imaging findings and the result of bone marrow biopsy, we believe that thet of Nuclear Medicine, Kaohsiung Medical University Hospital, No. 100 Tzyou 1st Road, San-Ming
org.tw (Y.-W. Chen).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
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230 C.-Y. Lin et al.disseminated malignant spread in bone marrow is a primitive alternation in the super bone
scan and that it is also as a result of neoplasm-related endocrine factors.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Whole body technetium-99m methyldiphosphonate (Tc-99m
MDP) bone scan is one of the most commonly performed
radionuclide examinations. The normal skeletal-to-renal
ratio of absorption of radioisotope is 40e60% [1,2]. A
super scan is defined as a bone scan that demonstrates
markedly increased skeletal radioisotope uptake relative to
soft tissue, and it is usually associated with absent or faint
genitourinary tract radioactivity [3]. Similar to the super
scan of bone scintigraphy, fluorine-18-fluorodeoxyglucose
positron emission tomography (18F-FDG PET) super scan
involving the skeleton has been reported [4]. Increased
skeletal-to-renal uptake ratios obtained with bone-seeking
radiotracers have been associated with a variety of disor-
ders [5]. In case of a super scan, skeletal uptake is very
rapid and the percentage of injected Tc-99m MDP going to
bone can be up to 85% [6]. Under this condition, a false-
negative diagnosis may occur in clinical settings. Super
scans have been described in relation to a variety of
conditions such as metastatic disease, metabolic bone
disease, and myeloproliferative disorders [1]. The imaging
pattern of super bone scan in a variety of conditions is still
different. For example, the characteristics of metastatic
disease is diffuse heterogeneous radioactivity in the axial
skeleton in the main, but diffuse homogeneous radioac-
tivity in both the appendicular and axial skeletons in
myeloproliferative disorders [1,7]. In metabolic disease,
the super bone scan pattern is more uniform with periph-
eral skeletal distribution, including appendicular, skull and
long bones.
The use of 18F-FDG PET or computed tomography (CT) in
the evaluation and management of patients with malig-
nancy continues to increase. The radiopharmaceutical
agent has the advantage of demonstrating all metastatic
sites, and in the skeleton, it is taken to represent metab-
olism of tumor cells. In comparison with Tc-99m MDP bone
scan, 18F-FDG PET is more valuable for identifying bone-
marrow-based disease as multiple myeloma [8]. In breast
cancer, 18F-FDG PET is highly sensitive mainly in diagnosis
of early metastatic disease, which may still be confined to
the bone marrow, as well as for the detection of lytic bone
metastases [9]. 18F-FDG PET also conveys the status of
glucose metabolism in bone marrow when hematopoietic
cytokine level changes [10].
We collected two patients with super bone scan, one
with initial diagnosis of stage IV gastric cancer and the
other with recurrent breast cancer. Both cases had 18F-FDG
PET/CT diagnosis simultaneously. The cytological results of
bone marrow biopsy demonstrated evidence of malignant
metastasis. We compared these two super bone scan
patterns in detail and the imaging of Tc-99m MDP bone scan
and 18F-FDG PET/CT individually. The molecular mechanism
of bone marrow metastasis resulting in the diffuse highbone turnover status of the super bone scan is proposed,
based on a recent literature review.
Case presentations
Case 1
A 43-year-old man had suffered from low back pain for 3
months in 2007, before he came to our hospital. Tc-99m MDP
bone scan and magnetic resonance imaging (MRI) were
arranged for evaluation. TheTc-99mMDPbone scan revealed
a super scan pattern with high skeletal-to-renal ratio
(Fig. 1A). Pelvic MRI showed multiple marrow metastatic
infiltrations. Bone marrow biopsy demonstrated metastatic
carcinoma. Immunohistochemical staining revealed positive
cytokeratin (CK)7 and faint CK20 characteristics, which had
possible origins in the gastrointestinal system, such as the
pancreas, liver, and stomach. Under clinic diagnosis of
cancer of unknown primary site, 18F-FDG PET/CT (GE, DST
16, USA) was arranged for further evaluation. The 18F-FDG
PET/CT imaging revealed a low-grade 18F-FDG-avid tiny
nodule (w1.1 cm) with a maximal standard uptake value
(SUVmax) of 3 in the bodyportion of the stomach. Endoscopic
biopsy showed grade III adenocarcinoma. No regional lymph
nodal radioactivity was identified on 18F-FDG PET/CT
imaging. Based on whole body 18F-FDG PET/CT imaging,
functional bilateral kidneys were identified. Extensively
disseminated, increased 18F-FDGuptake in the axial skeleton
was noted (Fig. 1B). Diffuse severe osteoporosis pattern was
noted in the pelvis and sacrum on CT. High-grade 18F-FDG
avid hypodensemetastatic tumor (SUVmax 9) in T12 was also
noted (Fig. 1C). Thus, a poor prognosis, stage IV gastric
cancer was diagnosed.
Case 2
A 57-year-old woman had been diagnosed with left breast,
infiltrating ductal carcinoma, stage IIA (T2N0M0) in 1994.
She received modified radical mastectomy, hormonal
therapy and regional radiotherapy. Thereafter, she had
regular follow-up in our clinic. There was no evidence of
bone metastases on serial Tc-99m MDP bone scan before
2005. In May 2010, she experienced poor appetite and
demonstrated severe body weight loss. High serum carci-
noembryonic antigen level was noted as 80 ng/mL. Whole
body 18F-FDG PET/CT was indicated for suspicious recur-
rent breast cancer. On 18F-FDG PET/CT imaging, bilateral
functioning kidneys were identified. However, extensively
increased marrow metabolism was noted in the axial
skeleton (Fig. 2A), associated with mild osteoporosis
pattern in the pelvic bones on CT. Under the impression of
severe metastatic bone marrow disease, bone marrow
biopsy was performed. The immunohistochemical stain
Figure 1. (A) In the patient diagnosed with gastric cancer, technetium-99m methyldiphosphonate bone scan revealed super bone
scan pattern with absent renal radioactivity and diffusely mild heterogeneous skeletal radioactivity throughout the whole axial
skeleton, ribs, head of clavicle, sternum, scapulae, proximal humeri and femora. (B) The 18F-FDG PET scan showed extensively
incremental 18F-FDG avid bone marrow metabolism with SUVmax 3 in the axial skeleton (significantly in ileum and sacrum) and
proximal humeri and femora. (C) Focally high grade of 18F-FDG avidity (SUVmax 9) was noted in T12. PET/computed tomography
fusion imaging identified a space occupied by a consistently high grade of 18F-FDG avid hypodense tumor associated with peripheral
osteolysis (arrow). 18F-FDG PET Z 18-fluorodeoxyglucose positron emission tomography; SUVmax Z maximal standard uptake
value.
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receptor and Her2/neu. The Tc-99m MDP bone scan
consistently showed a super bone scan pattern (Fig. 2B).
Significant left arm lymphedema was also noted. She
received chemotherapy, targeted therapy, and bisphosph-
onate for advanced breast cancer. After 1 year of aggres-
sive treatment, she underwent an 18F-FDG PET/CT scan to
evaluate treatment response, which revealed significantly
reduced axial skeletal bone marrow activity (Fig. 2C). The
follow-up Tc-99m MDP bone scan showed bilateral renal
and soft tissue radioactivity, which was not consistent with
typical imaging pattern of super bone scan (Fig. 2D).
However, some progressive radioactivity in the left prox-
imal femur was noted. The patient is still being followed
up in our hospital.Discussion
Cancer metastasis is the major cause of morbidity and
death in cancer patients. The hypothesis of organ-specific
metastasis is widely accepted. In 1889, Paget first proposed
the “seed and soil” theory to describe metastasis. He
considered the processes of metastasis did not occur by
chance; rather, certain favored tumor cells with metastatic
ability (the seed) had a specific affinity for the growth-
enhancing milieu within specific organs (the soil, microen-
vironment) [11,12]. Bone marrow and bone are the
environments with abundant blood flow and growth factors.
Once the tumor successfully metastasizes to the bone
marrow, it will trigger complicated interactions that are
regulated by various growth factors among the tumor,
Figure 2. At initial diagnosis of recurrent breast cancer, 18F-FDG PET/CT and Tc-99m MDP bone scan were performed. (A) 18F-FDG
PET/CT showed incrementally high grade of 18F-FDG avid marrow metabolism (SUVmax 8) in the axial skeleton. (B) Tc-99m MDP
bone scan revealed a typical super bone scan pattern. After aggressive cytotoxic treatment 1 year later, the follow-up images were
shown as (C) 18F-FDG PET/CT revealed treatment response, with significantly reduced axial skeletal bone marrow metabolism
(SUVmax 4). (D) Tc-99m MDP bone scan revealed bilateral renal and soft tissue radioactivity, which was not consistent with typical
imaging pattern of super bone scan. CT Z computed tomography; 18F-FDG PET Z 18-fluorodeoxyglucose positron emission
tomography; SUVmax Z maximal standard uptake value; Tc-99m MDP Z technetium-99m methyldiphosphonate.
232 C.-Y. Lin et al.osteoclasts and osteoblasts, resulting in different types of
bone metastasis. It is clear that bone microenvironment is
fertile for the growth of breast, prostate and lung cancer.
Bone metastasis occurs in 70% of patients with advanced
breast and prostate cancer, in terms of osteotropic tumor
[13]. In cancers of the thyroid, lung and kidneys bone
metastasis occurs in 30e40% of patients, but in cancers
from the gastrointestinal tract, bone metastasis is found in
<10% of cases. In metastasis-related super bone scan,prostate cancer is the most common cause, with up to 17%
[14]. In women, breast cancer is the most common cause
[15]. In this study, we collected one case of gastric cancer
with initial diagnosis of stage IV bone metastasis, and one
case of breast cancer with recurrence after 20 years. Both
cases had a super bone scan pattern, which is rare for such
cases in the literature.
Characteristics of the metastatic super bone scan
imaging patterns of both cases were diffuse heterogeneous
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and 2B). However, the distribution varied. We know that in
imaging of gastric cancer patients, higher MDP avid radio-
activity is distributed through flat bones such as the iliac
crest, sternum and proximal end femur, which have red
marrow distribution [12,13]. By contrast, our case of breast
cancer showed higher MDP avid radioactivity in the lumbar
spine. Furthermore, regional photopenia was noted in the
left upper ribs, probably related to prior radiotherapy. Both
cases had positive bone marrow biopsies, which represent
a heterogeneous massive tumor burden in the bone cavity,
associated with diffuse high bone turnover [16,17].
According to the above findings, it was still uncertain
whether the threshold of tumor burden or a chemical entity
was related to the condition of the super bone scan. In
comparison with 18F-FDG PET/CT imaging, incremental 18F-
FDG avidity (SUVmax 8e9) was consistent with the super
bone scan pattern in the breast cancer patient (Fig. 2A and
B). However, there was some discrepant distribution
between 18F-FDG PET/CT and bone scan in the gastric
cancer case (Fig. 1A and B). There was a focal high 18F-FDG
uptake in T12 (SUVmax 9) (Fig. 1C). This phenomenon
represents diffuse high bone turnover, where super bone
scan is not only consistent with diffuse tumor burden, but
also certain neoplasm-related endocrine factors, such as
parathyroid hormone-related peptide (PTHrP) [13]. In an
osteolytic metastasis model of breast cancer [18,19],
breast cancer cells secrete PTHrP binding the parathyroid
hormone 1 receptor that induces formation of osteoclasts.
In turn, bone resorption by osteoclasts releasing growth
factors from bone matrix that stimulate tumor growth and
bone destruction. Both present cases contained abundant
tumor burden as shown on 18F-FDG PET/CT imaging and
showed a super bone scan pattern. Interestingly, in the
case of breast cancer, the phenomenon of super bone scan
was reversible after aggressive treatment (Fig. 2B and D),
which is an uncommon result. To the best of our knowledge,
this has not often been mentioned before. Reversible super
bone scan after cytotoxic therapy still demonstrates the
relationship between osteotrophic metastatic neoplasm
cells and bone marrow/bone microenvironment [13,18,19].
It would be an interesting and valuable area of research to
establish large-scale clinical correlation based on different
cancer entities in the future.
Molecular medicine provides new clues to explain the
regulation of the microenvironment in bone marrow/bone-
related to stem cells [20,21]. Super bone scan represent
a diffuse high bone turnover rate, as noted in 1975, and it is
due to diffuse infiltrating marrow metastasis. Based on the
seed-and-soil theory, the initiation of super bone scan is not
only the result of massive osteotrophic metastatic cancer
infiltrating the bone marrow/bone microenvironment, but
also triggering of serial endocrine systems.
In conclusion, according to integration of both imaging
findings and results of bone marrow biopsy, the authorsconsider that disseminated malignant spread in bone
marrow and also neoplasm-related endocrine factors
support the phenomenon of a super bone scan.References
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